Epithelioid trophoblastic tumor (EТТ) is an extremely rare form and unusual type of trophoblastic tumor. In 1998 ЕТТ became an independent entity because it was characteristic for some specific histological and immunohistochemical features which made it different from placental site tumor and choriocarcinoma. ЕТТ origins from intermediate trophoblast and it can overlap with squamous cell carcinoma as per differential diagnosis.
ABSTRACT
Epithelioid trophoblastic tumor (EТТ) is an extremely rare form and unusual type of trophoblastic tumor. In 1998 ЕТТ became an independent entity because it was characteristic for some specific histological and immunohistochemical features which made it different from placental site tumor and choriocarcinoma. ЕТТ origins from intermediate trophoblast and it can overlap with squamous cell carcinoma as per differential diagnosis.
Literature data suggest that surgical treatment is a treatment of choice for ETT considering that its response to chemotherapy is considerably poor. A 35 years old patient G3 P2 came to an examination due to low pelvic pain and absence of menstrual cycle. For anamnesis, she reported that menstrual cycles were irregular for the past year. During bimanual pelvic examination, a painful tumefaction being approximately 8 cm was palpated in the pouch of Douglas. The patient was operated on as being suspected for ectopic pregnancy when it was noticed that the aforementioned tumefaction is located retroperitoneally immediately against rectosigmoid part of the colon. After the pathohistological analysis of the sample, in order to make final diagnosis, the immunohistochemical test was performed and it found that this was epithelioid trophoblastic tumor (EТТ). Due to an inadequate response to administered chemotherapy, both resection of rectosigmoid colon with appurtenant tumor and left hepatectomy with salpingectomy on both sides were performed considering a possibility of GTN after ectopic pregnancy. Because of dehiscence of colorectal anastomosis, relaparotomy with colostomy bag fitting was performed. The patient died on day 40 after surgical treatment due to hepatic insufficiency. KEYWORDS: ectopic pregnancy, gestational trophoblastic neoplasia, epithelioid trophoblastic tumor. Mostly, ETT occurs after term pregnancies. Value of β-hCG at a time when diagnosis is made is increased, but unlike choriocarcinoma, it generally does not exceed about 2500 mlU/ml. (5,6) Shih and Kurman reported a rate of metastasis being 25% and rate of mortality being 10% in ETT. (1)According to our knowledge, literature has described 94 cases of ETT so far.
CASE REPORT
A 35 years old patient G3 P2 was sent by a gynecologist to our institution due to low pelvic pain and absence of menstrual cycle. For anamnesis, she reported that menstrual cycles were irregular for the past year. During bimanual pelvic examination, a painful tumefaction being approximately 8 cm was palpated in the pouch of Douglas. An ultrasound view clearly differentiated uterus and both ovaries while the left ovary was located immediately against the aforementioned tumefaction which appeared like hematic mass within the pouch of Douglas. Blood test results were within normal ranges including complete blood count, biochemical parameters and tumor markers ( Ca -125, Ca 19-9, HE-4 and Roma index )except for increased value of β-hCG which was 198.70 mIU/ml. In view of the aforementioned symptomatology, which was presented as low pelvic pain and absence of menstrual cycle, as well as an inadequate increase in β-hCG, which was 220.01 mIU / ml after 48 hours, it was decided to operate the patient in order to explore adnexa.
The patient was operated on ( on 24 August 2016) as being suspected for ectopic pregnancy when it was noticed that the aforementioned tumefaction is located retroperitoneally immediately against rectosigmoid part of the colon. A surgeon was invited for consultations, a sample was taken for biopsy ( ex tempore-malignant ) and he proposed that further treatment was to be decided after obtaining the final histopathological finding and after additional diagnostic procedures. After pathohistological analysis of the sample, in order to make final diagnosis, immunohistochemical test was performed and it found that this was gestational trophoblastic neoplasia (GTN), i.e. epithelioid trophoblastic tumor (EТТ) with a suggestion that due to possibility of immunoprofile overlapping, it is necessary to exclude existing of squamous cell carcinoma within anal and genital area. Colonoscopy found polyps in rectosigmoid junction and a sample was taken for a biopsy. X-ray pictures of the head and lungs were regular. After diagnostic procedures had been finished,FIGO scores was 11 and the patient was in high risk group, so multi-agent chemotherapy was indicated. The patient was administered two cycles of cytostatic therapy ( Methoterxate + Cyclophosphamide) in accordance with a protocol for poor prognosis GTN. In this case The therapy was administered as per the following mode: Metotrexate dose of 1 mg/kg, as intramuscular injections on day one, day three, day five and day seven plus folic acid dose of 25 to 30mg on day two, day four, day six and day eight.
Cyclophoshamid dose of 300 mg was administered intravenously. On day seven, after administered chemotherapy, the patient received blood due to severe anemia. Dynamic in changes of β-hCG value during the treatment did not present any significant deviations from the initial value ( at admission 198.70 mIU/ml, at discharge 323.44 mIU/ml). Radiotherapy is also possible, while resection of metastasis is recommended for all cases when feasible. (11) When it comes to rare diseases which do not have established treatment protocols, in order to make as much as adequate decision on a treatment method , it is necessary to have team work with multidisciplinary approach. Despite the fact that application of diagnostics could have been faster and more precision and that applied treatment, primarily surgical, was awaited for some time, we believe that this would not have any influence on the treatment outcome considering the fact that it was the late stage of the disease. Surgical resection of the tumor is a primary method for treating ETT. There is neither any standard nor effective chemotherapy protocol due to very small number of cases. Therapy mode varies greatly, and chemotherapy can be administered before surgical treatment and after surgical treatment.
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